• Synergistic Effects of Copper and Hexetidine on Oral Strepto

  2026-04-30

  Grytten et al. demonstrated that combining copper and hexetidine yields a strong synergistic antibacterial effect against Streptococcus sobrinus and S. sanguis in vitro. This synergy, quantified by low fractional inhibitory concentration indices, highlights the value of combination strategies for targeting oral pathogens and informs methodology for future antibacterial resistance research.

• p-Cresyl Sulfate in Endothelial Dysfunction and CKD Models

  2026-04-30

  p-Cresyl sulfate is redefining mechanistic and translational research into cardiovascular and renal complications of chronic kidney disease. This article delivers workflow-ready guidance and troubleshooting for leveraging APExBIO's high-quality p-Cresyl sulfate in endothelial dysfunction, aortic valve calcification, and uremic toxin clearance studies.

• Sulfo-NHS-SS-Biotin: Advancing Cleavable Protein Labeling

  2026-04-29

  Explore how Sulfo-NHS-SS-Biotin empowers translational researchers to interrogate cell surface protein dynamics, with mechanistic insights, protocol guidance, and strategic perspectives informed by recent breakthroughs in mitochondrial proteostasis and apoptosis.

• Diphenyleneiodonium Chloride: Advanced Redox and cAMP Pathwa

  2026-04-29

  Explore how Diphenyleneiodonium chloride (DPI) uniquely enables advanced probing of redox and cAMP signaling pathways. This article delivers a deeper mechanistic perspective and integrates novel findings for assay optimization, setting it apart from standard application guides.

• TEAD Proteins Link Hippo Pathway to Ferroptosis in Liver Can

  2026-04-28

  This study identifies TEAD family transcription factors, especially TEAD2, as prognostic markers and regulators of ferroptosis in hepatocellular carcinoma (HCC). By integrating bioinformatics and experimental validation, the work clarifies TEAD2's upregulation in HCC and its influence on tumor cell susceptibility to ferroptotic cell death, offering new directions for cancer biology research.

• Thiamet G in Ferroptosis and Preeclampsia: Beyond Neurodegen

  2026-04-28

  Discover how Thiamet G, a potent O-GlcNAcase inhibitor, enables advanced interrogation of O-GlcNAcylation in ferroptosis and placental biology, with implications for preeclampsia models. This in-depth analysis reveals cutting-edge applications distinct from traditional tauopathy or osteogenic research.

• Givinostat Restores CBS Folding in Murine Homocystinuria Mod

  2026-04-27

  This study introduces a high-throughput, cell-based folding reporter assay to identify pharmacological chaperones for cystathionine beta-synthase (CBS) deficiency, a cause of homocystinuria. Givinostat, a histone deacetylase inhibitor, demonstrated the ability to rescue misfolded CBS and reduce disease biomarkers in mouse models, offering a framework for future drug repositioning efforts.

• HOBt in Translational Peptide Chemistry: Mechanisms & Impact

  2026-04-27

  Explore how HOBt (1-Hydroxybenzotriazole) enables high-fidelity amide bond formation, underpins next-generation bioactive molecule synthesis, and provides a strategic edge for translational researchers—integrating mechanistic insight with actionable protocol guidance and competitive benchmarking.

• Phosphorylation Clusters in FRQ Define Circadian Period and

  2026-04-26

  This study systematically dissects the functional role of 110 phosphorylation sites on the circadian clock protein FRQ in Neurospora, revealing that specific clusters, rather than individual sites, dictate period length and temperature compensation. The findings advance understanding of multisite protein phosphorylation and its impact on clock robustness, with practical implications for phosphorylation analysis methodologies.

• Alternariol-Induced Hepatic Stellate Activation in Liver Fib

  2026-04-25

  This study establishes that Alternariol (AOH), a prevalent Alternaria mycotoxin, directly induces hepatic stellate cell transdifferentiation, a pivotal event in liver fibrosis. Through omics-guided mechanistic analysis, it reveals the involvement of NF-κB, ferroptosis, and autophagy pathways, and introduces CotA laccase as a potential detoxification strategy, providing new directions for mycotoxin research and risk management.

• PNU 74654: Redefining Wnt/β-catenin Signaling Inhibition in

  2026-04-24

  Explore how PNU 74654, a potent Wnt signaling pathway inhibitor, enables unprecedented precision in dissecting β-catenin-driven processes in muscle regeneration and cancer research. This article uniquely integrates mechanistic innovation with advanced protocol guidance and critical evaluation of the latest WNT5a/GSK3/β-catenin axis findings.

• Improved In Vitro Drug Response Metrics in Cancer Research

  2026-04-24

  Schwartz's dissertation critically examines how conventional in vitro assays conflate proliferative arrest and cell death when evaluating anti-cancer drug efficacy, introducing a two-metric approach that distinguishes between growth inhibition and cytotoxicity. This refined methodology provides a clearer understanding of drug action, enhancing assay interpretation and translational relevance for cancer biology research.

• NIR-Triggered Cobalt Single-Atom Enzyme Boosts Multimodal Ca

  2026-04-23

  This study introduces a near-infrared (NIR)-activated cobalt single-atom enzyme (Co-SAE) anchored on hollow N-doped carbon spheres, enabling synergistic photodynamic, photocatalytic, and photothermal therapy for head and neck cancer. The work demonstrates enhanced generation of highly reactive oxygen species (hROS) and improved tumor ablation, offering a blueprint for noninvasive, function-preserving multimodal cancer treatments.

• Novobiocin: Aminocoumarin Antibiotic for Antimicrobial Workf

  2026-04-23

  Harness Novobiocin’s dual action as an aminocoumarin antibiotic and Hsp90 inhibitor for advanced antibacterial, antiparasitic, and antiviral assays. This guide delivers evidence-backed protocols, workflow enhancements, and troubleshooting strategies to maximize experimental impact and reproducibility.

• Cholesterol Sensing by Frizzled5 Drives Wnt/β-Catenin in PDA

  2026-04-22

  This study uncovers a novel mechanism whereby Frizzled5 (Fzd5) directly binds cholesterol, enabling its palmitoylation, maturation, and plasma membrane trafficking in pancreatic cancer. The findings reveal how aberrant cholesterol metabolism converges with Wnt/β-catenin signaling to support tumor growth, offering mechanistic insight and highlighting new therapeutic targets.

15026 records 1/1002 page Next 12345 下5页 Last page